Skip to content

Clinical trials

Withdrawn Phase 1/2 Lymphoma, B-Cell, Marginal Zone trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 1/2 Status: Withdrawn Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20102
20141
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology1
Louisiana State University Health Sciences Center Shreveport1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1
Mayo Clinic1
National Cancer Institute (NCI)1
University of Nebraska1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Follicular7
Lymphoma, Mantle-Cell7
Leukemia, Lymphocytic, Chronic, B-Cell5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Burkitt Lymphoma4
Leukemia, Myeloid, Acute4
Lymphoma4
Lymphoma, Non-Hodgkin4
Myeloproliferative Disorders4

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.